6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
4H77

Hubei Honch Pharmaceutical Co. Ltd

About Hubei Honch Pharmaceutical Co. Ltd

Hubei Honch Pharmaceutical Co Ltd was established in 2007 and now covers more than 25,000 square meters. We specialize in research, production and sales of anti-tumor APIs and veterinary APIs .

In the field of anti-tumor drugs, we are integrating innovative drugs and generic drugs, such as Ixabepilone, Bortezomib, Vinorelbine Tartrate, etc. Some drugs have got cGMP, CEP and passed international inspection and on-site audit.

In the filed of veterinary drugs, we mainly produce Melbemycine oxime, selamectin and Tulathromycin which are under the process of FDA.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
Contact info
  • Li shizhen Pharmaceutical Industrial Park, 435300, Hubei, Qichun County, China

Products from Hubei Honch Pharmaceutical Co. Ltd (10)